First Wave BioPharma Inc
NASDAQ:ENTO
First Wave BioPharma Inc
NASDAQ:ENTO
Price:
2.85
USD
-5.32%
Market Closed
Market Cap:
$9.6m
Cash Flow Statement
Cash Flow Statement
First Wave BioPharma Inc
First Wave BioPharma Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(15)
|
(16)
|
(18)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Other Non-Cash Items |
3
|
1
|
6
|
|
| Cash Interest Paid |
0
|
0
|
0
|
|
| Change in Working Capital |
(11)
|
2
|
3
|
|
| Cash from Operating Activities |
(22)
N/A
|
(12)
+45%
|
(9)
+26%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
0
|
0
|
0
|
|
| Other Items |
0
|
(1)
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(1)
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
23
|
16
|
6
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
|
| Other |
(7)
|
0
|
0
|
|
| Cash from Financing Activities |
16
N/A
|
15
-3%
|
6
-63%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
|
| Net Change in Cash |
(7)
N/A
|
2
N/A
|
(4)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(22)
N/A
|
(12)
+45%
|
(9)
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
